| Application no. and date | 21755119.1 (espacenet) (Federated) (European Patent Register), 20210706 | | Patent/reg. no. and date | DK/EP 4178548, 20240724 | | Publication date | 20230517 | | Priority no. and date | US 202063048998 P, 20200707 | | EP pub. no. and date |
EP 4178548 20230517 | | Effective date | | | Applicant/owner | Celgene Corporation, Route 206 & Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V478353DK00 | | Inventor | AGRAWAL, Anjali,
Summit, NJ 07901, US,
THOOL, Prajwal, Gunwanth,
Summit, NJ 07901, US,
MITRA, Biplob, K.,
Summit, NJ 07901, US,
HIGGINS-GRUBER, Shannon,
Summit, NJ 07901, US,
RODRIGUEZ, Jennifer, Almodovar,
Summit, NJ 07901, US,
LIU, Demin,
Summit, NJ 07901, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61K 9/16 (2006.01) , A61K 9/48 (2006.01) , A61P 1/00 (2006.01) , A61P 35/00 (2006.01) | | Title | Farmaceutiske sammensætninger omfattende (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUORBENZONITRIL | | Int. application no. | US2021040452 | | Int. publication no. | WO2022010854 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
